Search form
Search
contact us
Navigation
home
boards
job ratings
cp wire
medtech news
pharmagather
catering
advertise
Legal Help
login/register
You are here
Home
»
companies
» diabetes
diabetes
Medtronic Is Sweet on EOFlow
Medtronic Is Sweet on EOFlow
Medical Devices and Diagnostics Industry
Medtronic
diabetes
Medtech
M&A
EOFlow
Flag link:
What you need to know about pharma, PBM execs testifying on insulin prices
What you need to know about pharma, PBM execs testifying on insulin prices
Medical Marketing and Media
PBMs
insulin
diabetes
drug pricing
Sanofi
Novo Nordisk
Eli Lilly
Flag link:
No Layoffs Here: Senseonics to Expand Sales Team
No Layoffs Here: Senseonics to Expand Sales Team
Medical Devices and Diagnostics Industry
Medtech
Senseonics
Eversense
continuous glucose monitoring
diabetes
Flag link:
Medtronic diabetes warning letter lifted by FDA
Medtronic diabetes warning letter lifted by FDA
Medtech Dive
Medtronic
Medtech
diabetes
FDA
Flag link:
Medtronic wins FDA approval for long-delayed MiniMed 780G insulin pump
Medtronic wins FDA approval for long-delayed MiniMed 780G insulin pump
Medtech Dive
Medtronic
FDA
Medtech
MiniMed 780G
insulin pumps
diabetes
Flag link:
See you later, Baqsimi: Lilly sells low blood sugar rescue treatment to Amphastar for $500M-plus
See you later, Baqsimi: Lilly sells low blood sugar rescue treatment to Amphastar for $500M-plus
Fierce Pharma
Eli Lilly
Baqsimi
Amphastar
hypoglycemia
diabetes
Flag link:
What spurred Lilly, Novo and Sanofi to slash insulin prices? Expert gives her take
What spurred Lilly, Novo and Sanofi to slash insulin prices? Expert gives her take
Fierce Pharma
Novo Nordisk
Eli Lilly
Sanofi
insulin
diabetes
drug prices
Flag link:
Novo’s latest deal targets cell therapy for diabetes, obesity
Novo’s latest deal targets cell therapy for diabetes, obesity
BioPharma Dive
Novo Nordisk
cell therapy
diabetes
obesity
Aspect Biosystems
Flag link:
Bernie Sanders weighs Senate hearing for largest insulin makers
Bernie Sanders weighs Senate hearing for largest insulin makers
Seeking Alpha
Bernie Sanders
diabetes
insulin
drug pricing
Eli Lilly
Sanofi
Novo Nordisk
Senate
Flag link:
Abbott’s CGM Readers Face Class I Recall Over Lithium-ion Battery Issues
Abbott’s CGM Readers Face Class I Recall Over Lithium-ion Battery Issues
Medical Devices and Diagnostics Industry
Abbott Labs
device recalls
Medtech
diabetes
FreeStyle Libre
Flag link:
Abbott glucose monitor readers could catch fire, FDA warns in recall notice
Abbott glucose monitor readers could catch fire, FDA warns in recall notice
Stat
Abbott Labs
Medtech
FDA
product recalls
diabetes
blood glucose monitoring
Flag link:
Eli Lilly Spends Big on First Mounjaro TV Commercial for Diabetes
Eli Lilly Spends Big on First Mounjaro TV Commercial for Diabetes
Xtalks
Eli Lilly
Mounjaro
DTC ads
television ads
diabetes
Flag link:
Novo Nordisk Seeks to Solidify Its Lead in Diabetes Treatment and Crushing the Market
Novo Nordisk Seeks to Solidify Its Lead in Diabetes Treatment and Crushing the Market
Motley Fool
Novo Nordisk
diabetes
Ozempic
Rybelsus
Flag link:
Diabesity drugs and their free ‘contract sales force’
Diabesity drugs and their free ‘contract sales force’
Medical Marketing and Media
Novo Nordisk
Eli Lilly
diabetes
obesity
telehealth
social media
Mounjaro
Wegovy
Flag link:
Biomea goes for $125M offering after early diabetes data nearly doubled stock price
Biomea goes for $125M offering after early diabetes data nearly doubled stock price
Endpoints
Biomea Fusion
diabetes
clinical trials
Flag link:
Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality
Vertex ponies up $100M for CRISPR's gene editing tech to develop new diabetes modality
Endpoints
Vertex Pharmaceuticals
diabetes
CRISPR
gene editing
CRISPR Therapeutics
Flag link:
Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries
Novo's high-dose Rybelsus win tees up regulatory filings—and new rivalries
Fierce Pharma
Novo Nordisk
Rybelsus
diabetes
clinical trials
Eli Lilly
Flag link:
The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win
The Ozempic Obesity Battle Is Heating Up With Novo Scoring A Fresh Win
Investors Business Daily
Novo Nordisk
Ozempic
diabetes
obesity
Flag link:
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
CP Wire
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Flag link:
Most-clicked pharma news for week ending March 25: PTC Therapeutics CEO retires and Novartis' Zolgensma shows sustained efficacy
PTC Therapeutics
Novartis
Zolgensma
SMA
Novo Nordisk
Ozempic
obesity
diabetes
Baxter
M&A
Celltrio
Thermo Fisher
Pfizer
Astellas
Xtandi
NIH
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »